Eppendorf announces epMotion Software Extension, Enhanced Feature Set GxP, to support regulatory compliance in GxP environments
Today, Eppendorf, a renowned leader in the life science industry announces the launch of the revised Enhanced Feature Set GxP software extension for epMotion automated liquid handlers. The extension is designed to support customers operating in GxP environments and to achieve compliance with critical regulations such as 21 CFR Part 11, EU GMP Annex 11, and GAMP® 5.
In regulated industries, maintaining compliance with stringent guidelines is paramount. With the introduction of Enhanced Feature Set GxP for epMotion, Eppendorf offers laboratories around the world a product that not only enhances operational efficiency but also provides robust solution for regulatory adherence.
Enhanced Feature Set GxP for epMotion is designed with a focus on addressing the challenges of GxP environments including features like electronic signatures, audit trail, revision, and user management, offering a comprehensive solution for organizations seeking to streamline their compliance processes.
Dr. Martin Kohlstaedt, Innovation Manager Automation at Eppendorf, commented on the launch, "We understand the importance of compliance in GxP environments. Therefore, we designed Enhanced Feature Set GxP for our trusted epBlue automation software to provide our customers a solution to help addressing the challenging process to become compliant with critical regulations."
For more information aboutEnhanced Feature Set GxP and its capabilities, please visit www.eppendorf.com/automation
About the Eppendorf Group
Eppendorf is a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world. The product portfolio of the business units Liquid Handling, Consumables, Separation & Instrumentation and Bioprocess includes, for example, pipettes, pipette tips, centrifuges, mixers, ultra-freezers and bioreactors for cell and gene research. In addition, Eppendorf offers a wide range of high-quality consumables.
In fiscal year 2022, the Eppendorf Group generated €1.23 billion in sales and invested €76 million in research and development (R&D). Eppendorf products are used in academic and industrial research laboratories, for example in companies in the pharmaceutical, biotech, chemical and food industries. But Eppendorf products are also used in clinical or environmental analysis laboratories, in forensics and in industrial laboratories for process analysis, production, and quality assurance.
Eppendorf was founded in 1945, is headquartered in Hamburg, Germany, operates production and R&D sites in Europe, Asia and North America and has subsidiaries in 33 countries. Today, the Group employs more than 5,000 people worldwide. They all act in accordance with the purpose of the company's founders: to improve human living conditions.